Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas. Mod Pathol. 2003;16(9):879-885.Cook, J.R. , Craig, F.E. & Swerdlow, S.H. ( 2003 ) Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas . Modern Pathology , ...
巴西University Hospital of the Federal University of Santa Catarina的Chandra Cardoso等人在《The Importance of CD39, CD43, CD81 and CD95 Expression for Differentiating B Cell Lymphoma by Flow Cytometry》一文中总结了CD39、CD43、CD81和CD95在CD10+B-NHL中的鉴别诊断作用。文章共总结了27例患者,其中11...
弥漫大B细胞淋巴瘤(diffusedlargeBcelllym— phoma,DLBCL)是非霍奇金淋巴瘤(NHL)中最大 的一个亚群,是成人最常见的NHL[,约占NHL总 数的30%一40%l2l.在WHO关于淋巴系统肿瘤 的分类l3_中,DLBCL被定义为:B细胞起源的,有大 的肿瘤细胞,具有侵袭性临床表现,需要高效力化疗 ...
CD10,BCL6,and MUM1 expression in diffuse large B-cell lymphoma on FNA samples[J].Cancer Cytopathol, 2016,124(2):135-143. doi: 10.1002/cncy.21626 . 返回引文位置Google Scholar 百度学术 万方数据 [13] Shannon F , Marie LM , Isabelle C ,et al. Galectin-1 Is Implicated in the ...
【摘要】目的:探讨CD10、BCL-6及MUM1在弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma, DLBCL)亚型中的表达及临床病理意义.方法:应用免疫组织化学方法S-P法检测并比较89例DLBCL标本中CD10、BCL-6及MUM1的表达水平.结果:CD10、BCL-6及MUM1在89例DLBCL中的阳性表达率分别为11.24%(10/89)、29.21%(26/...
Objective:To investigate the clinical and prognostic signiifcance of EphA2 expression in diffuse large B-cell lymphoma (DLBCL). Methods:Immunohistochemistry for EphA2/CD10/Bcl-6/MUM-1 was performed on tissue sections from 51 patients diagnosed with DLBCL, and its correlation with clinicopathologic ...
keywords:bcl 2;bcl 6;cd10;diffuselargeb celllymphoma;immunohistochemistry 弥漫性大b细胞淋巴瘤(diffuselargeb celllymphoma,dlbcl)是成人最常见的、高度恶性的非霍奇金淋巴瘤(non hodgkin'slymphomas,nhl),约占成人nhl的40%[1 3],尽管who将其列为一种独立的疾病类型,但它实际上是一类异质性的淋巴瘤,应用传统...
Introduction: Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in adults. Although studies regarding the association between the expression of Ki-67, CD 10, BCL6, and MUM1 proteins, as well as c-MYC amplification and EBV status with clinicopatholog...
Mantle cell lymphoma (MCL) is a mature B-cell lymphoma characterized by expression of CD5, overexpression of Cyclin D1 as a result of chromosomal translocation t(11;14)(q13;q32), and poor prognosis. Cases of MCL lacking CD5 expression as well as cases with coexpression of CD5 and CD1...
Objective: We evaluated the value of using a panel of GC B-cell (CD10 and Bcl-6) and activation (MUM1, CD138 and Bcl-2) markers by immunohistochemistry to define prognosis in patients with diffuse large B-cell lymphoma (DLBCL). Methods: Two different models (Hans' and modified Chang's...